BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bagyinszky E, Giau VV, Youn YC, An SSA, Kim S. Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases. Neuropsychiatr Dis Treat 2018;14:2067-85. [PMID: 30147320 DOI: 10.2147/NDT.S165445] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Mol MO, van der Lee SJ, Hulsman M, Pijnenburg YAL, Scheltens P, Seelaar H, van Swieten JC, Kaat LD, Holstege H, van Rooij JGJ, Netherlands Brain Bank. Mapping the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families. Alz Res Therapy 2022;14:77. [DOI: 10.1186/s13195-022-01018-3] [Reference Citation Analysis]
2 Kim E, Na DL, Kim H, Park KW, Lee J, Roh JH, Kwon JC, Yoon SJ, Jung N, Jeong JH, Jang J, Kim H, Park KH, Choi SH, Kim S, Park YH, Kim BC, Youn YC, Ki C, Kim S, Seo SW, Kim Y. Genetic Screening in Korean Patients with Frontotemporal Dementia Syndrome. ADR 2022. [DOI: 10.3233/adr-220030] [Reference Citation Analysis]
3 Liang L, Yan J, Huang X, Zou C, Chen L, Li R, Xie J, Pan M, Zou D, Liu Y. Identification of molecular signatures associated with sleep disorder and Alzheimer’s disease. Front Psychiatry 2022;13:925012. [DOI: 10.3389/fpsyt.2022.925012] [Reference Citation Analysis]
4 Nagata T, Shinagawa S, Kobayashi N, Kondo K, Shigeta M. A case of V180I genetic mutation Creutzfeldt Jakob disease (CJD) with delusional misidentification as an initial symptom. Prion 2022;16:7-13. [PMID: 34965177 DOI: 10.1080/19336896.2021.2017701] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nguyen TT, Nguyen TTD, Tran NM, Van Vo G. Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders. Neurochem Res 2021. [PMID: 34800247 DOI: 10.1007/s11064-021-03488-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Colizzi M, Antolini G, Passarella L, Rizzo V, Puttini E, Zoccante L. Additional Evidence for Neuropsychiatric Manifestations in Mosaic Trisomy 20: A Case Report and Brief Review. Children 2021;8:1030. [DOI: 10.3390/children8111030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang J, Chu M, Tian Z, Xie K, Cui Y, Liu L, Meng J, Yan H, Ji YM, Jiang Z, Xia TX, Wang D, Wang X, Zhao Y, Ye H, Li J, Wang L, Wu L. Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions. J Neurol Neurosurg Psychiatry 2021:jnnp-2021-327247. [PMID: 34667102 DOI: 10.1136/jnnp-2021-327247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Bortot LO, Rangel VL, Pavlovici FA, El Omari K, Wagner A, Brandao-Neto J, Talon R, von Delft F, Reidenbach AG, Vallabh SM, Minikel EV, Schreiber S, Nonato MC. Novel quaternary structures of the human prion protein globular domain. Biochimie 2021;191:118-25. [PMID: 34517052 DOI: 10.1016/j.biochi.2021.09.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Bergasa-Caceres F, Rabitz HA. Identification of Two Early Folding Stage Prion Non-Local Contacts Suggested to Serve as Key Steps in Directing the Final Fold to Be Either Native or Pathogenic. Int J Mol Sci 2021;22:8619. [PMID: 34445324 DOI: 10.3390/ijms22168619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 DeCristo DM, Milko LV, O'Daniel JM, Foreman AKM, Mollison LF, Powell BC, Powell CM, Berg JS. Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making. Genome Med 2021;13:50. [PMID: 33781310 DOI: 10.1186/s13073-021-00867-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
11 Tan TH, Stark RJ, Waterston JA, White O, Thyagarajan D, Monif M. Genetic prion disease: D178N with 129MV disease modifying polymorphism-a clinical phenotype. BMJ Neurol Open 2020;2:e000074. [PMID: 33681799 DOI: 10.1136/bmjno-2020-000074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Carosi JM, Denton D, Kumar S, Sargeant TJ. Retromer dysfunction at the nexus of tauopathies. Cell Death Differ 2021;28:884-99. [PMID: 33473181 DOI: 10.1038/s41418-020-00727-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
13 Mbizvo GK, Ziso B, Larner AJ. Epilepsy and prion diseases: A narrative review. Epilepsy Behav 2021;115:107630. [PMID: 33309427 DOI: 10.1016/j.yebeh.2020.107630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
14 Parobkova E, van der Zee J, Dillen L, Van Broeckhoven C, Rusina R, Matej R. Sporadic Creutzfeldt-Jakob Disease and Other Proteinopathies in Comorbidity. Front Neurol 2020;11:596108. [PMID: 33329348 DOI: 10.3389/fneur.2020.596108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Bortot LO, Rangel VL, Pavlovici FA, Omari KE, Wagner A, Brandao-neto J, Talon R, von Delft F, Reidenbach AG, Vallabh SM, Minikel EV, Schreiber S, Nonato MC. Novel quaternary structures of the human prion protein globular domain.. [DOI: 10.1101/2020.11.16.385856] [Reference Citation Analysis]
16 Alves RN, Iglesia RP, Prado MB, Melo Escobar MI, Boccacino JM, Fernandes CFL, Coelho BP, Fortes AC, Lopes MH. A New Take on Prion Protein Dynamics in Cellular Trafficking. Int J Mol Sci 2020;21:E7763. [PMID: 33092231 DOI: 10.3390/ijms21207763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Xiao K, Zhou W, Gao LP, Wu YZ, Wang Y, Chen C, Gao C, Shi Q, Dong XP. Clinical and Laboratory Features of Three Rare Chinese V210I gCJD Patients. Pathogens 2020;9:E800. [PMID: 32998248 DOI: 10.3390/pathogens9100800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Ramos C, Aguillon D, Cordano C, Lopera F. Genetics of dementia: insights from Latin America. Dement Neuropsychol 2020;14:223-36. [PMID: 32973976 DOI: 10.1590/1980-57642020dn14-030004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
19 Kim YC, Won SY, Jeong BH. Identification of Prion Disease-Related Somatic Mutations in the Prion Protein Gene (PRNP) in Cancer Patients. Cells 2020;9:E1480. [PMID: 32560489 DOI: 10.3390/cells9061480] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
20 Trubitsina NP, Zemlyanko OM, Bondarev SA, Zhouravleva GA. Nonsense Mutations in the Yeast SUP35 Gene Affect the [PSI+] Prion Propagation. Int J Mol Sci 2020;21:E1648. [PMID: 32121268 DOI: 10.3390/ijms21051648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Cullingham CI, Peery RM, Dao A, McKenzie DI, Coltman DW. Predicting the spread-risk potential of chronic wasting disease to sympatric ungulate species. Prion 2020;14:56-66. [PMID: 32008428 DOI: 10.1080/19336896.2020.1720486] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
22 Piazza M, Prior TW, Khalsa PS, Appleby B. A case report of genetic prion disease with two different PRNP variants. Mol Genet Genomic Med 2020;8:e1134. [PMID: 31953922 DOI: 10.1002/mgg3.1134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Lee J, Chang I. Structural insight into conformational change in prion protein by breakage of electrostatic network around H187 due to its protonation. Sci Rep 2019;9:19305. [PMID: 31848406 DOI: 10.1038/s41598-019-55808-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Lee J, Chang I, Yu W. Atomic insights into the effects of pathological mutants through the disruption of hydrophobic core in the prion protein. Sci Rep 2019;9:19144. [PMID: 31844149 DOI: 10.1038/s41598-019-55661-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Giau VV, Bagyinszky E, Youn YC, An SSA, Kim S. APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease. Int J Mol Sci 2019;20:E4757. [PMID: 31557888 DOI: 10.3390/ijms20194757] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
26 Giau VV, Bagyinszky E, An SSA. Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment. Int J Mol Sci 2019;20:E4149. [PMID: 31450692 DOI: 10.3390/ijms20174149] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
27 Bagyinszky E, Yang Y, Giau VV, Youn YC, An SSA, Kim S. Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt-Jakob disease. Clin Interv Aging 2019;14:1387-97. [PMID: 31447551 DOI: 10.2147/CIA.S210909] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Bernardi L, Bruni AC. Mutations in Prion Protein Gene: Pathogenic Mechanisms in C-Terminal vs. N-Terminal Domain, a Review. Int J Mol Sci 2019;20:E3606. [PMID: 31340582 DOI: 10.3390/ijms20143606] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
29 Bagyinszky E, Kang MJ, Pyun J, Giau VV, An SSA, Kim S. Early-onset Alzheimer's disease patient with prion (PRNP) p.Val180Ile mutation. Neuropsychiatr Dis Treat 2019;15:2003-13. [PMID: 31410005 DOI: 10.2147/NDT.S215277] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
30 Giau VV, Bagyinszky E, Yang YS, Youn YC, An SSA, Kim SY. Genetic analyses of early-onset Alzheimer's disease using next generation sequencing. Sci Rep 2019;9:8368. [PMID: 31182772 DOI: 10.1038/s41598-019-44848-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 68] [Article Influence: 16.3] [Reference Citation Analysis]
31 He R, Hu Y, Yao L, Tian Y, Zhou Y, Yi F, Zhou L, Xu H, Sun Q. Clinical features and genetic characteristics of two Chinese pedigrees with fatal family insomnia. Prion 2019;13:116-23. [PMID: 31122137 DOI: 10.1080/19336896.2019.1617027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
32 Giau VV, Senanarong V, Bagyinszky E, An SSA, Kim S. Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer's Disease. Int J Mol Sci 2019;20:E1514. [PMID: 30917570 DOI: 10.3390/ijms20061514] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
33 Di Fede G, Catania M, Atzori C, Moda F, Pasquali C, Indaco A, Grisoli M, Zuffi M, Guaita MC, Testi R, Taraglio S, Sessa M, Gusmaroli G, Spinelli M, Salzano G, Legname G, Tarletti R, Godi L, Pocchiari M, Tagliavini F, Imperiale D, Giaccone G. Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene. Acta Neuropathol Commun 2019;7:1. [PMID: 30606247 DOI: 10.1186/s40478-018-0656-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
34 Okemoto-nakamura Y, Tanida I, Yamaji T, Hanada K, Hagiwara K. A <i>PRNP</i>-Disrupted Human Neuroblastoma Cell Line and Its Stable Transformants Expressing Prion Protein Variants. BPB Reports 2019;2:73-79. [DOI: 10.1248/bpbreports.2.5_73] [Reference Citation Analysis]